The Role of Lapatinib Ditosylate Monohydrate in Advanced Breast Cancer Treatment
Lapatinib Ditosylate Monohydrate stands as a pivotal molecule in the ongoing battle against advanced and metastatic breast cancer, particularly in cases where HER2-receptor positive tumors are involved. As a potent dual tyrosine kinase inhibitor, it targets both the HER2/neu and epidermal growth factor receptor (EGFR) pathways. This dual action is critical for disrupting cancer cell growth and proliferation, offering a vital treatment option when other therapies have proven insufficient.
For pharmaceutical manufacturers and researchers, sourcing high-quality Lapatinib Ditosylate Monohydrate is paramount. NINGBO INNO PHARMCHEM CO.,LTD. serves as a reliable manufacturer and supplier, offering this API with a guaranteed purity exceeding 99%. This high purity is essential for ensuring the efficacy and safety of the final drug product. We understand the rigorous demands of the pharmaceutical industry, which is why we adhere to strict quality control measures, including GMP and ISO certifications, making us a trusted Lapatinib Ditosylate supplier.
The efficacy of Lapatinib Ditosylate Monohydrate is well-documented in combination therapies. It is frequently prescribed alongside capecitabine or letrozole, demonstrating its versatility in treating postmenopausal women with hormone-receptor positive and HER2-receptor positive metastatic breast cancer. For procurement professionals, understanding the product's specifications, such as its yellow powder appearance and CAS number 388082-78-8, is key to making informed purchasing decisions. If you are looking to buy Lapatinib Ditosylate Monohydrate, consider the advantages of partnering with a dedicated manufacturer that prioritizes quality and a stable supply chain.
NINGBO INNO PHARMCHEM CO.,LTD. not only provides competitive Lapatinib Ditosylate Monohydrate price points but also offers flexible delivery options, including local warehouse availability in the USA and EU. This logistical advantage ensures that research institutions and manufacturing facilities can access this crucial pharmaceutical intermediate without significant delays. We are committed to supporting your drug development pipeline with consistent quality and expert service. Contact us today to learn more about our Lapatinib Ditosylate Monohydrate offerings and how we can meet your specific sourcing needs.
Perspectives & Insights
Future Origin 2025
“This logistical advantage ensures that research institutions and manufacturing facilities can access this crucial pharmaceutical intermediate without significant delays.”
Core Analyst 01
“We are committed to supporting your drug development pipeline with consistent quality and expert service.”
Silicon Seeker One
“Contact us today to learn more about our Lapatinib Ditosylate Monohydrate offerings and how we can meet your specific sourcing needs.”